Glomerulonephritis mit MPGN-Muster und verwandte Formen
- 5 December 2024
- journal article
- research article
- Published by Springer Nature in Die Nephrologie
- Vol. 20 (1) , 26-32
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Iptacopan in Idiopathic Immune Complex–Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 StudyKidney International Reports, 2023
- C3 glomerulopathy: Understanding an ultra‐rare complement‐mediated renal diseaseAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2022
- Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathyKidney International, 2022
- Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohortPediatric Nephrology, 2021
- Membranoproliferative Glomerulonephritis und C3‑GlomerulopathieDie Innere Medizin, 2019
- C3 Glomerulopathy: Ten Years' Experience at Mayo ClinicMayo Clinic Proceedings, 2018
- Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcomeMolecular Immunology, 2016
- Diagnosis of complement alternative pathway disordersKidney International, 2016
- „State-of-the-art“: C3-Glomerulopathie und membranoproliferative GlomerulonephritisDer Nephrologe, 2015
- C3 Glomerulonephritis/CFHR5 Nephropathy Is an Endemic Disease in Cyprus: Clinical and Molecular Findings in 21 Families2012